Asthma

In the midst of the COVID-19 pandemic, it is important that individuals who are at higher risk for poor outcomes from infection with vaccine-preventable diseases remain up-to-date with their immunizations.

Smart inhalers have the potential to address the challenges faced by patients and health care professionals in the management of respiratory diseases.

Those wearing a facemask while exercising may feel an increased sensation of dyspnea, however, there is little evidence that this medical condition is occurring.

Frequent or chronic use of oral corticosteroids can lead to serious adverse effects in patients with asthma, including weight gain, diabetes, immunosuppression, and adrenal insufficiency.

Digital health tools were a major theme during the first-ever NASP Challenge, comprising 4 of the 5 finalists.

The triple combination therapy is the first single inhaler triple therapy approved for both asthma and COPD and is the only single inhaler triple therapy available as a once-daily inhalation.

Contrary to earlier statements from the CDC, study suggests corticosteroid inhalers used by many asthmatics might make it more difficult for COVID-19 to enter the airways.

New research contradicts previous observational studies on the effect of vitamin D supplements in severe asthma prevention.

Top news of the week from Pharmacy Times®.

As a chronic respiratory disease, asthma has been considered a risk factor for COVID-19 by many experts and clinicians.

The inhaler sends data back to a mobile app in real time.

Contrary to World Health Organization recommendations, the benefits of steroids used in inhalers and nebulizers outweigh the risks.

The dupilumab pen features a hidden needle and single-press auto-injection, along with visual and audio feedback to help with administration.

Generic products featured in the May 2020 issue.

Patients with COVID-19 between the ages of 20 and 59 years who also had asthma needed a ventilator to assist with breathing for 5 days more on average than non-asthmatic patients with COVID-19, according to a press release.

The National Institutes of Health (NIH) has issued a timely statement emphasizing the importance of asthma awareness and standing with parents, families, advocates, researchers, and health care professionals.

A study to help determine the incidence rate of the coronavirus disease 2019 (COVID-19) in children and their family members has begun enrolling participants in the United States, according to the National Institutes of Health (NIH).

Pharmacists should understand their mechanisms to facilitate high-quality, collaborative management with physicians.

Pharmacists can educate patients about the nonprescription asthma inhaler that recently returned to the market.

The American Lung Association (ALA) has started a $25M initiative to address the coronavirus disease 2019 (COVID-19) pandemic and other future respiratory virus pandemics.

This medication inhaler is indicated for the treatment or prevention of bronchospasm in patients ages 4 years and older who have reversible obstructive airway disease.

The study, which includes data from asthma patient samples and mouse models, is the first to definitively show a relationship between iron build-up in the lung cells and tissues and the severity of asthma, according to the researchers.

In the first report of its kind, a recent study compiled Korean Health Insurance Review and Assessment Service data from 2002 to 2013 to evaluate a bidirectional association between asthma and migraines in Korean adults.

The FDA is now requiring a boxed warning for montelukast (Singulair) to strengthen the existing warning about the risk of neuropsychiatric events.

The product will be immediately launched with limited commercial qualities, and manufacturers expect that there will be a steady supply by the fourth quarter of 2020.